Serial Number 97806670
Registration 7436832
700

Registration Progress

Application Filed
Feb 22, 2023
Under Examination
Approved for Publication
Apr 23, 2024
Published for Opposition
Apr 23, 2024
Registered
Jul 9, 2024

Trademark Image

Basic Information

Serial Number
97806670
Registration Number
7436832
Filing Date
February 22, 2023
Registration Date
July 9, 2024
Published for Opposition
April 23, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 9, 2024
Registration
Registered
Classes
001 005 042

Rights Holder

Amphista Therapeutics Limited

99
Address
Bahnhofstrasse 52
Zurich CH-8001
CH

Ownership History

Amphista Therapeutics Limited

Original Applicant
99
Cambridge GB

Amphista Therapeutics Limited

Owner at Publication
99
Cambridge GB

Amphista Therapeutics Limited

Original Registrant
99
Zurich CH

Legal Representation

Attorney
Rob LeBlanc

USPTO Deadlines

Next Deadline
1817 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-09)
Due Date
July 09, 2030
Grace Period Ends
January 09, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Apr 22, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 22, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 22, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 22, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 22, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 8, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Mar 4, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 1, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 1, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 30, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 20, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 14, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 13, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 25, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or medical research use
Class 005
Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Class 042
Scientific and technological services, namely, scientific analysis, testing, engineering, development, research, and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medicinal preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological substances and chemicals testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services

Additional Information

Design Mark
The mark consists of a stylized green triangle with a portion on the right side of the triangle having a gap in the middle and with the lower portion protruding upward.
Color Claim
The color(s) green is/are claimed as a feature of the mark.

Classification

International Classes
001 005 042